drugset / Trial / NCT01660477
Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole
Phase 1
Completed
68 enrolled
Astellas Pharma Global Development, Inc.
Basilea Pharmaceutica International Ltd · collab
RandomizedParallel-groupOpen-label
Summary
The purpose of this two part study is to assess the effect of multiple doses of isavuconazole on the pharmacokinetics of multiple doses of lopinavir/ritonavir and the effect of multiple doses of lopinavir/ritonavir on the pharmacokinetics of isavuconazole. Part 1 of the study includes 12 subjects randomized to receive either isavuconazole alone or isavuconazole in combination with lopinavir/ritonavir. The purpose of Part 1 is to evaluate safety and tolerability and to establish the effect of multiple doses of lopinavir/ritonavir on isavuconazole. Part 2, if initiated, includes 54 subjects randomized to receive isavuconazole alone, lopinavir/ritonavir alone, or isavuconazole in combination with lopinavir/ritonavir.
Timeline
- Start
- 2012-06
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isavuconazole | Small molecule | — | Oral |
| Subject | Lopinavir/ritonavir | Unknown | — | Oral |
Indications
No indication recorded.